Skip to main content
. Author manuscript; available in PMC: 2014 Feb 12.
Published in final edited form as: Lancet Oncol. 2013 Dec 11;15(1):69–77. doi: 10.1016/S1470-2045(13)70551-5

Table 2.

Summary of Grades 1 and 2 Adverse Events (n = 30)

Adverse Event Grade 1, n (%) Grade 2, n (%) Grade 3/4, n

Anemia 14 (47) 0 0
Fatigue 13 (43) 2 (7) 0
Leukopenia 11 (37) 0 0
Thrombocytopenia 8 (27) 2 (7) 0
Dyspnea 6 (20) 0 0
Neutropenia 5 (17) 1 (3) 0
Nausea 5 (17) 0 0
Sweating 4 (13) 0 0
Neuropathy 4 (13) 0 0
Cough 4 (13) 0 0
Pain 3 (10) 2 (7) 0
Edema 3 (10) 1 (3) 0
Pruritus 3 (10) 0 0
Diarrhea 3 (10) 0 0
Anorexia 3 (10) 0 0
Hypotension 2 (7) 1 (3) 0
Respiratory Infection 1 (3) 5 (17) 0